Stock AnalizAmrize (AMRZ) earnings for the quarter ended September 2026: EPS beats estimates
Amrize reported results for the quarter ended September 2026 on October 28, 2026. Adjusted earnings per share came in at $1.02 against the analysts’ average forecast of $1.00, a beat of 2.0%.
Revenue for the quarter was $3.77 billion, up 2.2% from $3.69 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 3.4% on the first trading day after the report.
The last four quarters
Amrize has beaten the analysts’ EPS forecast in 1 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $1.02 | $1.00 | +2.0% | +2% | +3.4% |
| Jun 2026 | $0.86 | $0.94 | −8.8% | +9% | −11.8% |
| Mar 2026 | -$0.21 | -$0.15 | −39.8% | +4% | −6.4% |
| Sep 2025 | $0.98 | $1.02 | −3.9% | +7% | +5.9% |
What comes next
Analysts expect EPS of $0.57 for the next quarter on average and $2.29 for the fiscal year ending December 31, 2026.
The average analyst price target is $45.02, 10% above the current price of $40.89.
Valuation and score
Amrize scores 1.6 out of 5 overall on Stock Analiz (weak), trades at a trailing P/E of about 18.0, and its intrinsic value under moderate assumptions is about 23% below the current market value. Full Amrize analysis with 10 years of financials
Frequently asked questions
What was Amrize’s EPS for the quarter ended September 2026?
$1.02 adjusted per share, against an analyst consensus of $1.00.
How much revenue did Amrize report?
$3.77 billion, up 2.2% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.